CYP1B1 and breast carcinoma: The aim of the present study was to analyze the associations between genetic polymorphisms in three estrogen metabolizing enzymes (COMT, CYP1A1, CYP1B1) and the two estrogen receptors (ESR1, ESR2) and the risk of developing breast cancer among women with BBD.